MPW Stock - Medical Properties Trust, Inc.
Unlock GoAI Insights for MPW
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $995.55M | $871.80M | $1.54B | $1.54B | $1.25B |
| Gross Profit | $968.29M | $830.23M | $1.50B | $1.51B | $1.22B |
| Gross Margin | 97.3% | 95.2% | 97.0% | 97.5% | 98.0% |
| Operating Income | $386.85M | $81.28M | $1.00B | $1.04B | N/A |
| Net Income | $-2,410,271,000 | $-556,476,000 | $902.60M | $656.02M | $431.45M |
| Net Margin | -242.1% | -63.8% | 58.5% | 42.5% | 34.5% |
| EPS | $-4.02 | $-0.93 | $1.50 | $1.11 | $0.81 |
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| March 12th 2025 | Exane BNP Paribas | Upgrade | Outperform | $9← $5 |
| September 13th 2024 | Colliers Securities | Upgrade | Buy | $6.5 |
| July 2nd 2024 | Exane BNP Paribas | Downgrade | Neutral | $4 |
| April 17th 2024 | Deutsche Bank | Upgrade | Hold | $5 |
| April 10th 2024 | Colliers Securities | Downgrade | Neutral | $4.25← $10 |
| March 1st 2024 | Exane BNP Paribas | Upgrade | Outperform | $6 |
| January 30th 2024 | Deutsche Bank | Initiation | Sell | $2 |
| January 5th 2024 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| November 10th 2023 | Stifel | Downgrade | Hold | $4.5← $12 |
| October 16th 2023 | Wells Fargo | Downgrade | Underweight | $4← $7 |
| October 11th 2023 | Exane BNP Paribas | Initiation | Neutral | $5.5 |
| August 31st 2023 | Mizuho | Downgrade | Neutral | $9← $18 |
| August 21st 2023 | JP Morgan | Downgrade | Underweight | $7← $9 |
| August 11th 2023 | Raymond James | Downgrade | Underperform | - |
| August 11th 2023 | BofA Securities | Downgrade | Underperform | $8← $9 |
Earnings History & Surprises
MPWEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.15 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.16 | $0.13 | -18.8% | ✗ MISS |
Q3 2025 | Jul 31, 2025 | $0.15 | $0.14 | -6.7% | ✗ MISS |
Q2 2025 | May 1, 2025 | $0.15 | $0.14 | -6.7% | ✗ MISS |
Q1 2025 | Feb 27, 2025 | $0.16 | $0.18 | +12.5% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.20 | $0.16 | -20.0% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $0.20 | $0.23 | +15.0% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.25 | $0.24 | -4.0% | ✗ MISS |
Q1 2024 | Feb 21, 2024 | $0.27 | $0.36 | +33.3% | ✓ BEAT |
Q4 2023 | Oct 26, 2023 | $0.35 | $0.38 | +8.6% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $0.38 | $0.48 | +26.3% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.37 | $0.37 | 0.0% | = MET |
Q1 2023 | Feb 23, 2023 | $0.43 | $0.43 | 0.0% | = MET |
Q4 2022 | Oct 27, 2022 | $0.30 | $0.37 | +23.3% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $0.45 | $0.46 | +2.2% | ✓ BEAT |
Q2 2022 | Apr 28, 2022 | $0.47 | $0.47 | 0.0% | = MET |
Q1 2022 | Feb 3, 2022 | $0.31 | $0.34 | +9.7% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.44 | $0.44 | 0.0% | = MET |
Q3 2021 | Jul 29, 2021 | $0.43 | $0.43 | 0.0% | = MET |
Latest News
Wells Fargo Maintains Underweight on Medical Properties Trust, Raises Price Target to $5
➖ NeutralMedical Properties Trust shares are trading higher after the company reported better-than-expected Q3 sales results and announced a $150 million stock repurchase program.
📈 PositiveMedical Properties Trust Approves $150M Stock Repurchase Program
📈 PositiveMedical Properties Trust Q3 FFO $0.13 Misses $0.15 Estimate, Sales $237.522M Beat $233.548M Estimate
➖ NeutralMedical Properties Trust Q3 earnings preview - Stock stands to gain if shorts continue to exit
📈 PositiveMedical Properties Trust continues gains for seven straight sessions
📈 PositiveYale New Haven Health System Settles With Prospect And Medical Properties Trust And Will Pay $45M To Prospect, MPT To Release Yale Of Obligation To Purchase Three Facilities
➖ NeutralMedical Properties Trust Announces A Lease Agreement With NOR Healthcare Systems Corp; The Six Facilities Will Be Subject To A Master Lease With Initial Annualized Rent Of $45M
📈 PositiveWells Fargo Maintains Underweight on Medical Properties Trust, Lowers Price Target to $4.5
📉 NegativeMedical Properties Trust to snap six straight sessions of decline
📈 PositiveMedical Properties Q2 earnings face a hit from interest expenses, troubled tenants
📉 NegativeCan Medical Properties beat FFO and revenue consensus again?
➖ NeutralFrequently Asked Questions about MPW
What is MPW's current stock price?
What is the analyst price target for MPW?
What sector is Medical Properties Trust, Inc. in?
What is MPW's market cap?
Does MPW pay dividends?
Similar Stocks
Real Estate SectorExplore stocks similar to MPW for comparison